What is Sk3 Group Inc?
provides management advisory, licensing, and marketing services for medical marijuana collectives in California.
SKTO · Verdict
Moderate reward · moderate risk
SKTO stands out on volatility and balance sheet, but watch the profitability signal.
Based on 75% data coverage
SKTO · Verdict
Above average
Current ratio 0.00
0% return on equity
In line with peers
Model-based scoring. For information only — not financial advice.
provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company is listed on the OTCCE in USA, operating in the Healthcare sector, with a market capitalisation of 1.52M.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.